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Abstract: Anxiety is a psychological problem that often emerges during the normal course of human
life. The detection of anxiety often involves a physical exam and a self-reporting questionnaire.
However, these approaches have limitations, as the data might lack reliability and consistency upon
application to the same population over time. Furthermore, there might be varying understanding
and interpretations of the particular question by the participant, which necessitating the approach of
using biomarker-based measurement for stress diagnosis. The most prominent biomarker related to
stress, hormone cortisol, plays a key role in the fight-or-flight situation, alters the immune response,
and suppresses the digestive and the reproductive systems. We have taken the endeavour to review
the available aptamer-based biosensor (aptasensor) for cortisol detection. The potential point-of-care
diagnostic strategies that could be harnessed for the aptasensing of cortisol were also envisaged.
Keywords: anxiety; cortisol; aptasensor; aptamer
1. Diagnosis of Stress
Stress is defined as the internal process of the body that results in a response to a demand or threat
(stressor) that is perceived to exceed the resources available to cope with it [1]. As stress can have many
negative consequences such as immune system suppression, elevated risk of heart disease/stroke,
aging, and infertility, an accurate diagnosis of stress is warranted [2]. Current strategies to diagnose
stress include self-reporting of stress, the measurement of the stress effects, the measurement of
stress exposure, and the assessment of biomarkers [3]. Among these strategies, biomarker-based
measurement appears to be unequivocal for the effective diagnosis of stress. Efficient interpretation of
biomarkers is able to provide excellent diagnosis of stress.
2. Cortisol as a Potential Stress Biomarker
The central component of the neuroendocrine system is the hypothalamus-pituitary-adrenal
(HPA) axis, which controls the response to stress, digestion, and emotions. In the presence of perceived
stress, the hypothalamus, which contains neurons, will secrete vasopressin and corticotrophin-releasing
hormone (CRH). This action triggers the production and secretion of adrenocorticotropic hormone
(ACTH) from the pituitary gland. Subsequently, the adrenal cortex is stimulated to produce
glucocorticoids, primarily cortisol. Cortisol has immunosuppressive and anti-inflammatory effects,
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increases heart rate and blood pressure, and represses growth, and digestive and reproductive activities.
Cortisol is also involved in the maintenance of energetic balance [4]. It also has a function in the
mediation of life history trade-offs [5] and allows for individuals to respond to disturbances in their
environment [6].
The glucocorticoids, including cortisol, repress the production of CRH and ACTH, as a negative
feedback response [7]. Since cortisol is the primary end product of the HPA axis, it can be employed as
an amenable biomarker for the diagnosis of stress. A significant deviation in the cortisol level from
the normal range in sweat, serum, and saliva is found to be associated with stress conditions [8–11]
substantiating the use of cortisol as a suitable biomarker for stress.
A potential biomarker of chronic disease defined by the recent use of hair cortisol measurements
prove that it gives a retrospective index of incorporating cortisol secretion over a period of several
months [12,13]. Over the last 20 years, hair sample testing has increased in recognition and
attention, especially for forensic purposes and the detection of illegal drugs. This is because hair
can keep a relatively long-term record of retrospective levels of various biomarkers in the body [14].
High-performance liquid chromatography (HPLC) ion spray mass spectrometry has been developed
for hair cortisol assay [15,16]. Increased hair cortisol in rhesus macaques has been linked with a
prolonged stressful experience. The immunoassay for testing hair cortisol has been developed by
Davenport et al. [17] during the third trimester of pregnancy. Kirschbaum et al. [18] found that
increased cortisol production has been systemically incorporated into growing hair by using the same
method. It has been able to provide a retrospective long-term history of cortisol exposure for up to six
months. A long-term follow-up study in the same individual can use these findings to indicate the
use of hair for sample cortisol levels. It also has a potential for biomarker use in stress applications.
Another famous cortisol sample type is by using blood or serum. Even though limited use in the
clinical laboratory, serological methods are able to provide high sensitivity and specificity [19].
Dispersion to all water spaces of the body, such as saliva, serum, and urine, is the characteristic
of cortisol secreted from adrenal glands. Urinary measures have the drawback of the inability to
determine rapid changes in the cortisol level. In clinical and research settings, serum measures are often
used but the stress from the venipuncture itself elevates the level of cortisol. Moreover, to perform daily
serial blood collection is not practical. Contrarily, salivary cortisol samples benefit from easy collection.
It is also present in the form of a bioactive fraction, but not in cortisol bound to cortisol-binding globulin
(CBG) or other proteins [20]. Using anti-cortisol antibodies, many immune-sensing applications of
cortisol have been developed for the diagnostic detection of stress, as summarized in Table 1. The
structure of cortisol is illustrated in Figure 1.
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Table 1. List of antibody-based cortisol sensing mechanisms with the probe, limit of detection (LOD),
advantages, and limitations.
Method Probe Lowest LODof Cortisol Advantage Limitation References
ELISA Monoclonalantibody -
• Stable reagents • Uses enzyme labelling [21]
Lateral Flow
Immunoassays
Colloidal
gold-labelled
primary
antibody
3.5 µg/L
• High sensitivity
• High selectivity
• Portable
• No washing step
• Semi-quantitative
or Qualitative
• Uncertain sample
volume reduce precision
[22]
Chemiresistor
Immunosensor
Monoclonal
antibody 1 pg/mL
• Label-free
• Rapid detection
of cortisol
• Non-specific adsorption
of mucin from saliva
[23]
Quartz Crystal
Microbalance
Monoclonal
antibody 11 pg/mL
• Label free
• Real
time measurement
• Measurement noise
caused by environment
[24]
Surface Plasmon
Resonance (SPR)
Monoclonal
antibody 10 µg/L
• Real
time measurement
• Rapid
• Safe
• High-selectivity
• High-sensitivity
• Pre-treatment procedure
to get better result [25]
Interdigitated
µ-Electrode
Monoclonal
antibody 1 pM
• Ultrasensitive
• label-free
Impedimetric biosensor
• Potential of
superimposed effects of
multi-electrode measurement
[26]
Polyaniline
protected gold
nanoparticles
(PPAuNPs)
Monoclonal
antibody 1 pM
• Improvement in
redox stability
and electro-activity
• pH might affect
the outcome [27]
3. Aptamers as a Potential Diagnostic Element That Can Replace Anti-Cortisol Antibodies
Although anti-cortisol antibodies have been applied in many immune sensing applications of
cortisol, antibodies generally have many limitations. Antibodies can be permanently denatured, and
the generation of antibodies requires animals for production [28]. Antibodies have batch-to-batch
variations [29]. The conjugation of antibodies is difficult and expensive [30]. These shortcomings of
antibodies can be addressed by aptamers [31].
Aptamers are single-stranded DNAs or RNAs that have high affinity and specificity against
the corresponding target [32]. Aptamers have reversible denaturation properties and are isolated
in vitro. Aptamers, unlike antibodies, exhibit no batch-to-batch variation [33]. Owing to the superior
properties of aptamers over antibodies, aptamers can be an elegant candidate to replace the counterpart
antibodies in diagnostic assays of cortisol.
4. In Vitro Isolation of Aptamers Against Cortisol
Cortisol is a very small molecule with a size of 362.46 Daltons. This small size could
complicate the conventional process of selecting aptamers by Systematic Evolution of Ligands
by EXponential enrichment (SELEX) (Figure 2). Therefore, tweaking of the conventional SELEX
is required so that binding sites of the target are available for the interaction with potential
aptamers. On this basis, some researchers [34] have designed a tunable stringency magnetic
bead selection strategy to generate aptamers against cortisol. This SELEX process was adopted
from a previously described method [35] in which aptamers were generated against four standard
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NTPs. In this method, structure-switching aptamers are directly isolated from the nucleic acid
library immobilized on the surface of the magnetic beads, which interacts with the target that is
free in the solution. This selection strategy differs significantly from the conventional selection
that generates aptamers, which can only interact with the target and most probably are unable
to undergo a conformational change that can be transduced into signal production. Martin
et al. (2014) immobilized the biotinylated capture probe on the surface of gold nanoparticles.
The capture probe was a 7-mer complementary to the 5′-end of the ssDNA library with the
sequence GAATGGATCCACATCCATGG-N40-TTCACTGCAGACTTGACGAAGCTTGACGAA. This
complementarity allows duplex formation between the capture probe and the ssDNA library. The
key to this selection strategy is that, once the target is added, the sequences that have an affinity for
the target will be released from the duplex formed initially with the capture probe. These sequences,
which are now bound to the target, can be separated from the unbound sequences by magnetic forces.
Stringency was gradually increased by increasing the length of the capture probe. This allows only
sequences with high affinity to be released from the duplex and bind to the target. Stringency was
increased from cycle 1 to cycle 10, but was decreased from cycle 11 to cycle 13 and was increased
again to cycle 15. A single sequence of aptamer 15 to 1 was isolated after 15 cycles of SELEX, which
demonstrated an equilibrium dissociation constant (Kd) value of 6.9 ± 2.8 µM, as estimated by
equilibrium dialysis, or 16.1 ± 0.6 µM, as estimated by microscale thermophoresis.
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Figure 2. Systematic Evolution of Ligands by EXponential enrichment (SELEX). The binding molecules
are selected from a randomiz d nucleic acid library. I itially, the nucleic acid library is incubated with
the target molecule. T en, the unbound nucleic acids are washed away, le ving only the molecules
that have bound to the target molecule. The target-bound nucleic acid molecules will be eluted and
amplified. Following amplification, the resulting double stranded DNA (dsDNA) will be converted
to ssDNA in the case of DNA aptamer generation. For RNA aptamer generation, the dsDNA will be
subjected to in vi r tra s ription to generate RNA pool. The resulting ssRNA/DNA pool will be used
for the subsequent round of SELEX. Several rounds of SELEX will be carried out till the isolation of
nucleic acid molecules that have high affinity and specificity against the target. The binding affinity of
the putative aptamers will be estimated.
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The Kd value is in accordance with the Kd values of aptamers selected against other small
molecules such as 17β-estradiol (0.9 µM) [36], kanamycin A (3.9 µM) [37], kanamycin A (2.8 µM) [38],
ketamine (0.59 µM) [39], or Pd II (4.60 ± 1.17 µM) [40]. The Kd value is in the micromolar range due to
the comparatively small size of the target to the aptamer [41].
5. Cortisol Aptasensor towards Point-of-Care Diagnostics
Point-of-care diagnostic is a type of in vitro diagnosis that enables the analysis of diseases to
be carried out anywhere, i.e., from the hospital to the field, for an instant answer to expedite rapid
treatment [42]. For a sensor to be used as a point-of-care diagnostic device, it should involve the
usage of a small sample volume, an inexpensive disposable platform, microfluidic features to control
sample flow, a reasonable reaction time, removal/masking of interfering agents, and an effective
measurement strategy [43,44]. To date, there are two applications of cortisol aptasensors. These
aptasensing applications potentially fulfill the criteria that qualify them as potential point-of-care
devices. Each of these aptasensing applications will be scrutinized to evaluate its capacity as a
point-of-care diagnostic device.
5.1. Gold Nanoparticles
One of the ideal assays for any point-of-care diagnostic application is a colorimetric assay that
enables detection of the target by the naked eye. One assay that is able to meet this criterion is the
gold nanoparticle-based assay. Compared to antibodies, aptamers are more compatible with the gold
nanoparticle-based assay due to the differential absorption of the aptamers onto the surface of the gold
nanoparticles in the presence and absence of the target, resulting in color changes [45]. Aptamers are
absorbed onto the surface of the gold nanoparticles due to the interaction between the nitrogenous
bases of the aptamers with gold atoms [46]. In the absence of the target, aptamers are absorbed onto the
surface of the gold nanoparticles and stabilize them against the NaCl-induced aggregation. The gold
nanoparticles are segregated which causes changes in the surface plasmon of the gold nanoparticles,
resulting in red colour production. However, in the presence of the target, aptamers are desorbed from
the surface of the gold nanoparticles, thus permitting Na+ to neutralize the negatively-charged citrate
ions on the surface of the gold nanoparticles. As a consequence, gold nanoparticles are aggregated,
which alters the surface plasmon and results in the production of blue color (Figure 3). Based on this
principle, aptamer generated against cortisol (Aptamer 15 to 1) was applied in the gold nanoparticle
assay, achieving a detection limit of 150–600 nM [34]. The detection limit corresponds to the normal
range of free cortisol (30 to 140 ng/mL or 100 to 500 nM) in human serum. The assay developed
exhibited remarkable specificity as it was found to be unresponsive to other stress biomarkers, such as
epinephrine and norepinephrine, and also non-selective against other structurally-similar molecules
of cortisol.
The high sensitivity and selectivity of the aptamer-based gold nanoparticle assay can be attributed
to the structure-switching property of the aptamer in the presence or absence of the target [47,48].
Further work was conducted to increase the DNA coverage from 73 DNA molecules per gold
nanoparticle (D/NP) to 120 to 200 D/NP. However, the limit of detection diminished as the coverage
increased, i.e., 29.5 nM for 73 D/NP, 145.2 nM for 120 D/NP, and 27.3 µM for 200 D/NP [49]. This
result was in agreement with studies conducted by Smith et al. (2014), who found that the limit of
detection decreased when the cocaine aptamer coverage was increased from 60 aptamers per gold
nanoparticle to 300 aptamers per gold nanoparticle [50]. Aptamer-based gold nanoparticles is highly
sensitive and specific without the requirement for any expensive instrumentation, suggesting that this
method can be a potential point-of-care diagnostic strategy for cortisol detection.
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Figure 3. The mechanism of the colorimetric detection of a small target molecule using aptamers.
In the presence of the target, aptamers are desorbed from the surface of AuNPs forming aptamer-target
complex. As a result, Na+ neutralizes the negatively charged citrate ion on the surface of AuNP.
This causes aggregation of the AuNPs and results in blue colour formation. In the absence of the
target, aptamers on the surface of AuNPs stabilizes th se nanoparticles gainst the NaCl-induced salt
aggregation, causes th production f red col ur.
5.2. Surface Immobilization-Free Electrochemical Detection of Cortisol
An immobilization-free electrochemical sensor can obviate the need for immobilizing the aptamer
on the electrode surface, as well as washing to remove the non-specifically-bound target or labeling
of the capture probe. In the assay developed by [51], target recognition by the aptamer and signal
production are independent and thus, c uld be optimized separately for better specificity. Figure 4
illustrates the m hanism of su face immobilization-free electrochemical detect on of cort sol. The
cortisol aptamer conjugated to gold nano articles is b und to triamcinolone, which is structurally
similar to cortisol. In the presence of cortisol in the sample, cortisol will displace triamcinolone
from the aptamer. As such, triamcinolone is electrochemically reduced on graphene-modified
electrodes. The graphene-modified glass electrodes were patterned on the coverslip glass by
lithography patterning within a nanoslit device. These patterned electrodes serve as the counter,
reference and working electrodes. Linearity was achieved within the range of 10 µg/mL to 30 pg/mL
without profound interferences from other glucocorticoids such as estradiol, progesterone, and
testosterone. The develop d assay is similar to ELISA nd radiolabeling but involves a shorter
assay time (2.5 mi ) and a smaller sample volume (<1 µL). The small sample volume a d faster
reaction time are in accordance with the criteria of point-of-care diagnostics, suggesting that surface
immobilization-free electrochemical detection of cortisol can be a potential point-of-care diagnostic
method for cortisol detection.
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6. Prophesying Aptamer-Based Lateral Flo Assay (LFA) for Cortisol Detection
The lateral flow assay (LFA) is one of the most sought after point-of-care diagnostic devices
as it is a mobile system that can provide a quantitative and qualitative measurement of the target.
LFA consists of a sample pad, conjugate pad, membrane pad and absorbent pad. The absorbent pad
provides the capillary effect for the flow of the sample, while the conjugate pad is usually dry and is
dispensed with the labeled molecular recognition elements (MRE). The labeled MRE binds to target in
the s mpl and carries it away. Du to c pillary action, the labe ed MRE-target complex encounters
anothe MRE immobilized on the surface of the test and control lines on the membrane pad. The
formation of the sandwich configuration that consists of the two MREs binding to the target causes
the appearance of the coloured visible lines on the test and control zones. The absorbent pad helps to
maintain the flow rate of the sample [52]. One format that can be adopted for the design of LFA for
the cortisol detection is the competitive format, inspired by the development of LFA for ochratoxin
A [53]. The single cortisol aptamer sequence can be extended with homopolymer poly d(A) with thiol
at the extremity and immobilized on the surface of AuNPs. In the test zone, a biotinylated probe that
is complementary to t e a tamer sequence [without the poly d(A)] is immobilized via streptavidin.
In the absence of the tar e , the aptamer-AuNP complex binds th c mplementary seque ce on the
test lines, causing the app arance of the visible line. In the pre ence of the arget in the sample, the
aptamer-AuNP conjugate will bind to the target and is thus unable to bind to the complementary
sequence. As such, there is no visible line on the test zone. To ensure the validity of the test, another
oligonucleotide, a poly d(T) oligonucleotide, which is complementary against the poly d(A) is also
biotinylated and conjugated via streptavidin onto the surface of the control zone. The intensity of the
lines on the test zone is inversely proportional to the amount of the target in the sample. Figure 5
highlights the elements of the LFA.
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an ther DNA polymerase family. Thus, circumspection sho ld b exerci ed when adopting aptam rs
in sensor that might result in f lse positive signal production.
8. Potential Development of Surface Plasmon Resonance (SPR)-Based Aptasensor
A sensor can be d scribed as a surface-sensitive optical technique to measure the biomolecular
interaction based on the changes of the surface plasmon on the metal surface [55,56]. The metal
surfac of a SPR immunosensor is excited with an incident light at a certain angle of incidence. The
immobilization of biomolecules and the subseque t interaction of the biomolecules with the interacting
partners cause the change in the reflectivity of th sensing medium. Subsequently, the reflectivity
change is measured by the detector, which is exploite to measure the biomolecular interaction.
SPR is able to study the biomolecular interaction in r al-time in response to the variation of the
effective refractive ind x of th medium [57]. This has been widely used in th field of pharmaceutical
devel pment and life scienc s [58–60]. Moreover, SPR-based affinity measurement could provide rapid,
highly sel ctive, safe, and highly sensitive m asurements wit out the eed of isotopes or fluorescence
labels [61,62]. Figure 6 sh ws the schematic diagram of the SPR yst m.
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can be amalgamated with the label-free way of measuring biomolecular interaction such as gold 
nanoparticles-based assay. Based on this foundation, the gold nanoparticle-based diagnostic system 
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sensor is acquired from the colorimetric assay-smartphone system developed for the detection of 
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Figure 6. Schematic of the surface plasmon resonance system. The changes in the reflected light I
and II influence the response of the system and can be used to determine the specimen. SPR-based
aptasensing can be employed for the detection of cortisol. Biotinylated aptamer against cortisol can be
immobilized on the surface of the Sensor chip streptavidin (SA). Reflectivity can be used to measure
the interaction of the aptamer with the cortisol.
Frasconi et al. have used a SPR-based immunosensor for real-time measurement of cortisone
and cortisol levels from samples of urine and saliva. They have used polycarbocylate-hydrogel-based
coating to immobilize the antibody. During repeated regeneration and affinity reaction cycles, the
sensor surface demonstrates a high level of stability. In addition to showing high specificity for
cortisone and cortisol, there is no profound interference from other types of steroids with similar
chemical structures. They also investigated the suitability of hydrogen coating, which prevent the
nonspecific binding. The proposed method has been correlated with liquid chromatography/tandem
mass spectrometry to measure the cortisone and cortisol in urine and saliva samples. The limit of
detection is less than 10 µg·L−1, which is sensitive enough for applications in clinical and forensic
use [30]. Similar application can be adopted to develop SPR-based aptasensing application of cortisol
detection. Biotinylated aptamer against cortisol can be immobilized on the surface of the Sensor chip
streptavidin (SA). Sample containing cortisol can be injected through the aptamer-immobilized chip
and the changes in the reflectivity can be deployed to measure the biomolecular interaction.
9. Sma tphone-Based Aptasensor
A simple, portable, affordable and sensitive sensor is a feasible diagnostic system that is able
to meet all the requirements of the ASSURED criteria of a point-of-care diagnostic system. These
requirements are inherent in the smartphones, which are portable and simple. Smartphone system
can be amalgamated with the label-free way of measuring biomolecular interaction such as gold
nanoparticles-based assay. Based on this foundation, the gold nanoparticle-based diagnostic system
using cortisol aptamer can be merged with the smartphone system. Inspiration on developing this
sensor is acquired from the colorimetric assay-smartphone system developed for the detection of
cocaine. The color changes in the presence and absence of the target were precisely measured by using
a fully-functional Android-based color analysis application. The color of an unknown sample can
be distinguished using this application and compared with positive references to provide a result as
to whether the tested substance is positive for cocaine [50]. Another envisaged smartphone-based
aptacortisol sensor could be exemplified from the assimilation of the smartphone with the filter-less
fluorescent assay using ultraviolet light. The aptamer is conjugated with pyrenes at the two extremities.
In the presence of the target, aptamer forms excimer. Due to the biomolecular recognition event, the
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Anti-cortisol aptamer can be adopted in the gold nanoparticles-based detection of cortisol and
embedded into the smartphone.
10. Conclusions
The current development of two cortisol aptasensors has evidenced the potentiality of paving
the trajectory towards using anti-cortisol aptamer in the point-of-care diagnostic. Aptamer-based
gold nanoparticles assay and surface immobilization-free electrochemical detection of cortisol meet all
the requirements of the ASSURED guidelines which are affordable, sensitive, specific, user-friendly,
rapid/robust, equipment-free and delivered. POCTs such as LFA, SPR and smartphone system
could also lay groundwork towards expending the current repertoire of aptamer-based assay of
detecting cortisol.
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